Development of New Products and Technologies through Industry-Academia Collaboration and Joint Research with Overseas Research Institutions
First written in FY2016. 25 of 31 entries say "Restated". Latest entry: FY2026-H1.
15 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The group's R&D expenses for the interim consolidated fiscal period were ¥43.237 million. There were no material changes in the group's research and development activities during the interim consolidated fiscal period.」
The company discloses R&D expenses of ¥43.237 million for the interim consolidated fiscal period and states that there were no material changes in its research and development activities. - FY2025AdvancedAnnual report
「The company established its Technology Development Department in April 2025 and will conduct market research for new product development, establish manufacturing technologies for high-value-added products, and develop new metal sulfide products for growth fields such as battery materials.」
The company established its Technology Development Department in April 2025 and is developing a system responsible for market research, establishing manufacturing technologies, and developing metal sulfides for battery materials. - FY2025-H1RestatedAnnual report
「The group's R&D expenses for the interim consolidated fiscal period were ¥59.544 million. There were no material changes in the group's research and development activities during the interim consolidated fiscal period.」
The company discloses R&D expenses of ¥59.544 million for the interim consolidated fiscal period and states that there were no material changes in its research and development activities. - FY2024-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥68.433 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company discloses cumulative third-quarter R&D expenses of ¥68.433 million and states that there were no material changes in its research and development activities. - FY2024-Q2RestatedAnnual report
「The group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥46.405 million. There were no material changes in the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company discloses cumulative second-quarter R&D expenses of ¥46.405 million and states that there were no material changes in its research and development activities. - FY2024-Q1RestatedAnnual report
「The group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥23.408 million. There were no material changes in the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company discloses cumulative first-quarter R&D expenses of ¥23.408 million and states that there were no material changes in its research and development activities. - FY2023-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥87.946 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities, including industry-academia collaboration and R&D in Japan and overseas, and reports cumulative third-quarter R&D expenses of ¥87.946 million. - FY2023-Q2RestatedAnnual report
「The group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥55.887 million. There were no material changes in the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities and reports cumulative second-quarter R&D expenses of ¥55.887 million. - FY2023-Q1RestatedAnnual report
「The group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥28.250 million. There were no material changes in the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities and reports cumulative first-quarter R&D expenses of ¥28.250 million. - FY2022RestatedAnnual report
「To develop markets for new products, the company is conducting basic research for new product development and developing new technologies in Japan and overseas through industry-academia collaboration with group companies and universities, which it has pursued to date. The group's total R&D expenses for the consolidated fiscal year were ¥95.744 million.」
The company continues its industry-academia collaboration, basic research in Japan and overseas, and new technology development. Annual R&D expenses were ¥95.744 million. - FY2022-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥72.607 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reports cumulative third-quarter R&D expenses of ¥72.607 million and reaffirms that there were no material changes in its research and development activities. - FY2022-Q2RestatedAnnual report
「The group's R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥42.029 million. There were no material changes in the group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
The company reports R&D expenses of ¥42.029 million and states that there were no material changes in its research and development activities. - FY2021-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥46.454 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities and reports cumulative third-quarter R&D expenses of ¥46.454 million. - FY2021-Q2RestatedAnnual report
「The group's R&D expenses for the second quarter of the current consolidated fiscal year were ¥31.146 million. There were no material changes in the group's research and development activities during the second quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities and reports R&D expenses of ¥31.146 million for the second quarter of the current consolidated fiscal year. - FY2021-Q1RestatedAnnual report
「The group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥14.001 million. There were no material changes in the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities and reports R&D expenses of ¥14.001 million for the first quarter of the current consolidated fiscal year. - FY2020AdvancedAnnual report
「The group's total R&D expenses for the consolidated fiscal year were ¥77.237 million. At the SULMICS plant, a metal sulfide manufacturing plant with an established production system, the company is producing trial products related to tin sulfide, for which a mass-production system has been established. It is also developing new products involving various metal sulfides, including copper sulfide and bismuth sulfide, by applying its proprietary technology. These products may be used in automotive applications, including solid-state batteries and solid lubricants.」
R&D expenses were ¥77.237 million. The company established a mass-production system for tin sulfide at the SULMICS plant and is developing new products involving copper sulfide, bismuth sulfide and other metal sulfides. - FY2020-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥59.286 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company reports R&D expenses of ¥59.286 million and states that there were no material changes in its research and development activities. - FY2020-Q1RestatedAnnual report
「The group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥19.750 million. There were no material changes in the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities, and reports R&D expenses of ¥19.750 million for the first quarter of the current consolidated fiscal year. - FY2019AdvancedAnnual report
「The industrial production facilities for tin sulfide that had been under development were completed, establishing the production system. The company is developing new products involving multiple metal sulfides by applying its proprietary technology.」
The industrial production facilities for tin sulfide were completed, establishing the production system. Development of new products involving multiple metal sulfides is continuing. - FY2019-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥43.647 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities, and reports cumulative R&D expenses of ¥43.647 million. - FY2019-Q2RestatedAnnual report
「The group's R&D expenses for the second quarter of the current consolidated fiscal year were ¥30.147 million. There were no material changes in the group's research and development activities during the second quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities, and reports R&D expenses of ¥30.147 million. - FY2019-Q1RestatedAnnual report
「The group's R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥15.578 million. There were no material changes in the group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
The company reports R&D expenses of ¥15.578 million and states that there were no material changes in its research and development activities. - FY2018AdvancedAnnual report
「To develop markets for new products, the company is conducting basic research for new product development and developing new technologies in Japan and overseas through industry-academia collaboration with group companies and universities, which it has pursued to date. The group's total R&D expenses for the consolidated fiscal year were ¥60.395 million. The company is developing new products, mainly metal sulfides, and has completed the design of a manufacturing plant for tin sulfide and moved to the construction phase.」
The company continues its industry-academia collaboration and R&D in Japan and overseas, and has completed the manufacturing plant design for tin sulfide and moved to the construction phase. R&D expenses were ¥60.395 million. - FY2018-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥46.581 million. There were no material changes in the group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
The company states that there were no material changes in its research and development activities, and reports cumulative R&D expenses of ¥46.581 million. - FY2018-Q2RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」
There have been no material changes in the company's research and development activities, and its existing policy of industry-academia collaboration and R&D in Japan and overseas continues. - FY2018-Q1RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」
There have been no material changes in the company's research and development activities, and its existing policy of industry-academia collaboration and R&D in Japan and overseas continues. - FY2017AdvancedAnnual report
「The total R&D expenses of the group for the consolidated fiscal year were ¥75.763 million. The company is developing new products, mainly metal sulfides. For some products under development, it has established new metal sulfide manufacturing technology jointly with overseas research institutions and is constructing the manufacturing process. It has also expanded its testing facilities and has been strengthening its systems to improve its ability to respond promptly to customer-driven product development.」
The company established new metal sulfide manufacturing technology jointly with overseas research institutions and has progressed to constructing the manufacturing process and expanding its testing facilities. R&D expenses were ¥75.763 million. - FY2017-Q3RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」
The company states that there have been no material changes in its research and development activities, and that its existing policy of industry-academia collaboration and R&D in Japan and overseas continues. - FY2017-Q2RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」
The company states that there have been no material changes in its research and development activities, and that its existing R&D policy continues. - FY2017-Q1RestatedAnnual report
「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」
The company states that there have been no material changes in its research and development activities, and that its existing R&D policy continues. - FY2016First statedAnnual report
「With respect to developing markets for new products, we are conducting basic research for new product development and developing new technologies in Japan and overseas through industry-academia collaboration with Group companies and universities.」
The Group is pursuing basic research and new technology development in Japan and overseas through collaboration with Group companies and universities.